Understanding the basis of antibiotic resistance: A platform for drug discovery

Microbiology (United Kingdom)

Volumn 160, Issue , 2014, Pages 2366-2373

  Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CHLORAMPHENICOL; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL VIRULENCE; BASIC RESEARCH; DNA SEQUENCE; DRUG DEVELOPMENT; DRUG RESISTANCE; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; DRUG EFFECTS; GENETICS; HISTORY; HUMAN; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA INFECTIONS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG DISCOVERY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 84908539534     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.082412-0     Document Type: Article

References (51)

1. Abouzeed, Y. M., Baucheron, S. & Cloeckaert A. (2008). ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 52, 2428–2434.
2. Alekshun, M. N. & Levy, S. B. (1999). The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol 7, 410–413.
3. Bailey, A. M., Paulsen, I. T. & Piddock, L. J. (2008). RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine. Antimicrob Agents Chemother 52, 3604–3611.
4. Bailey, A. M., Ivens, A., Kingsley, R., Cottell, J. L., Wain, J. & Piddock, L. J. (2010). RamA, a member of the AraC/XylS family, influences both virulence and efflux in Salmonella enterica serovar Typhimurium. J Bacteriol 192, 1607–1616.
5. Barbosa, T. M. & Levy, S. B. (2000). Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol 182, 3467–3474.
6. Baucheron, S., Tyler, S., Boyd, D., Mulvey, M. R., Chaslus-Dancla, E. & Cloeckaert, A. (2004). AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104. Antimicrob Agents Chemother 48, 3729–3735.
7. Baucheron, S., Coste, F., Canepa, S., Maurel, M. C., Giraud, E., Culard, F., Castaing, B., Roussel, A. & Cloeckaert, A. (2012). Binding of the RamR repressor to wild-type and mutated promoters of the ramA gene involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 56, 942–948.
8. Baugh, S., Ekanayaka, A. S., Piddock, L. J. & Webber, M. A. (2012). Loss of or inhibition of all multidrug resistance efflux pumps of Salmonella enterica serovar Typhimurium results in impaired ability to form a biofilm. J Antimicrob Chemother 67, 2409–2417.
9. Baugh, S., Phillips, C. R., Ekanayaka, A. S., Piddock, L. J. & Webber, M. A. (2014). Inhibition of multidrug efflux as a strategy to prevent biofilm formation. J Antimicrob Chemother 69, 673–681.
10. Blair, J. M. & Piddock, L. J. (2009). Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update. Curr Opin Microbiol 12, 512–519.
11. Blair, J. M., La Ragione, R. M., Woodward, M. J. & Piddock, L. J. (2009). Periplasmic adaptor protein AcrA has a distinct role in the antibiotic resistance and virulence of Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 64, 965–972.
12. Browning, D. F. & Busby, S. J. (2004). The regulation of bacterial transcription initiation. Nat Rev Microbiol 2, 57–65.
13. Buckley, A. M., Webber, M. A., Cooles, S., Randall, L. P., La Ragione, R. M., Woodward, M. J. & Piddock, L. J. (2006). The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cell Microbiol 8, 847–856.
14. Chollet, R., Chevalier, J., Bollet, C., Pages, J. M. & Davin-Regli, A. (2004). RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes. Antimicrob Agents Chemother 48, 2518–2523.
15. Cloeckaert, A. & Chaslus-Dancla, E. (2001). Mechanisms of quinolone resistance in Salmonella. Vet Res 32, 291–300.
16. de Cristbal, R. E., Vincent, P. A. & Salomón, R. A. (2006). Multidrug resistance pump AcrAB-TolC is required for high-level, Tet(A)- mediated tetracycline resistance in Escherichia coli. J Antimicrob Chemother 58, 31–36.
17. Garvey, M. I., Rahman, M. M., Gibbons, S. & Piddock, L. J. (2011). Medicinal plant extracts with efflux inhibitory activity against Gramnegative bacteria. Int J Antimicrob Agents 37, 145–151.
18. Gensberg, K., Jin, Y. F. & Piddock, L. J. (1995). A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium. FEMS Microbiol Lett 132, 57–60.
19. Griggs, D. J., Gensberg, K. & Piddock, L. J. (1996). Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals. Antimicrob Agents Chemother 40, 1009–1013.
20. Harder, K. J., Nikaido, H. & Matsuhashi, M. (1981). Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin. Antimicrob Agents Chemother 20, 549–552.
21. Heisig, P. (1993). High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes. J Antimicrob Chemother 32, 367–377.
22. Köhler, T., Michea-Hamzehpour, M., Plesiat, P., Kahr, A. L. & Pechere, J. C. (1997). Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 41, 2540–2543.
23. Lacroix, F. J., Cloeckaert, A., Grépinet, O., Pinault, C., Popoff, M. Y., Waxin, H. & Pardon, P. (1996). Salmonella typhimurium acrB-like gene: identification and role in resistance to biliary salts and detergents and in murine infection. FEMS Microbiol Lett 135, 161–167.
24. Lawler, A. J., Ricci, V., Busby, S. J. W. & Piddock, L. J. V. (2013). Genetic inactivation of acrAB or inhibition of efflux induces expression of ramA. J Antimicrob Chemother 68, 1551–1557.
25. Li, X. Z., Livermore, D. M. & Nikaido, H. (1994). Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother 38, 1732–1741.
26. Li, X. Z., Nikaido, H. & Poole, K. (1995). Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 39, 1948–1953.
27. Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S. & other authors (2001). Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 45, 105–116.
28. Mortimer, P. G. S. & Piddock, L. J. V. (1991). A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 28, 639–653.
29. Mortimer, P. G. S, & Piddock, L. J. V. (1993). The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli. J Antimicrob Chemother 32, 195–213.
30. Nishino, K., Latifi, T. & Groisman, E. A. (2006). Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium. Mol Microbiol 59, 126–141.
31. Oethinger, M., Kern, W. V., Jellen-Ritter, A. S., McMurry, L. M. & Levy, S. B. (2000). Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 44, 10–13.
32. Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. (2007). Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6, 29–40.
33. Piddock, L. J. (2006a). Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19, 382–402.
34. Piddock, L. J. (2006b). Multidrug-resistance efflux pumps – not just for resistance. Nat Rev Microbiol 4, 629–636.
35. Piddock, L. J. V., Whale, K. & Wise, R. (1990). Quinolone resistance in Salmonella: clinical experience. Lancet 335, 1459.
36. Piddock, L. J., Griggs, D. J., Hall, M. C. & Jin, Y. F. (1993). Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients. Antimicrob Agents Chemother 37, 662–666.
37. Piddock, L. J., White, D. G., Gensberg, K., Pumbwe, L. & Griggs, D. J. (2000). Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 44, 3118–3121.
38. Ricci, V. & Piddock, L. J. (2009a). Only for substrate antibiotics are a functional AcrAB-TolC efflux pump and RamA required to select multidrug-resistant Salmonella Typhimurium. J Antimicrob Chemother 64, 654–657.
39. Ricci, V. & Piddock, L. J. (2009b). Ciprofloxacin selects for multidrug resistance in Salmonella enterica serovar Typhimurium mediated by at least two different pathways. J Antimicrob Chemother 63, 909–916.
40. Ricci, V. & Piddock, L. J. (2010). Exploiting the role of TolC in pathogenicity: identification of a bacteriophage for eradication of Salmonella serovars from poultry. Appl Environ Microbiol 76, 1704–1706.
41. Ricci, V., Busby, S. J. & Piddock, L. J. (2012). Regulation of RamA by RamR in Salmonella enterica serovar Typhimurium: isolation of a RamR superrepressor. Antimicrob Agents Chemother 56, 6037–6040.
42. Ricci, V., Blair, J. M. & Piddock, L. J. (2014). RamA, which controls expression of the MDR efflux pump AcrAB-TolC, is regulated by the Lon protease. J Antimicrob Chemother 69, 643–650.
43. Robillard, N. J. (1990). Broad-host-range gyrase A gene probe. Antimicrob Agents Chemother 34, 1889–1894.
44. Schneiders, T., Amyes, S. G. B. & Levy, S. B. (2003). Role of AcrR and RamA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother 47, 2831–2837.
45. van der Straaten, T., Janssen, R., Mevius, D. J. & van Dissel, J. T. (2004). Salmonella gene rma (ramA) and multiple-drug-resistant Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 48, 2292–2294.
46. Webber, M. A., Randall, L. P., Cooles, S., Woodward, M. J. & Piddock, L. J. (2008). Triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 62, 83–91.
47. Webber, M. A., Bailey, A. M., Blair, J. M. A., Morgan, E., Stevens, M. P., Hinton, J. C. D., Ivens, A., Wain, J. & Piddock, L. J. V. (2009). The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host. J Bacteriol 191, 4276–4285.
48. White, D. G., Maneewannakul, K., von Hofe, E., Zillman, M., Eisenberg, W., Field, A. K. & Levy, S. B. (1997). Inhibition of the multiple antibiotic resistance (mar) operon in Escherichia coli by antisense DNA analogs. Antimicrob Agents Chemother 41, 2699–2704.
49. Wray, C., McLaren, I., Wise, R. & Piddock, L. J. V. (1990). Nalidixic acid-resistant salmonellae. Vet Rec 126, 489.
50. Yang, S., Lopez, C. R. & Zechiedrich, E. L. (2006). Quorum sensing and multidrug transporters in Escherichia coli. Proc Natl Acad Sci U S A 103, 2386–2391.
51. Zheng, D., Constantinidou, C., Hobman, J. L. & Minchin, S. D. (2004). Identification of the CRP regulon using in vitro and in vivo transcriptional profiling. Nucleic Acids Res 32, 5874–5893.